Search results
Imported Drugs: (Possibly) Coming Soon to a State Near You
The National Law Review· 4 hours agoAs we previously discussed, the US Department of Health and Human Services (HHS) issued a final rule...
Johnson & Johnson (JNJ) Up 5.5% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 7 hours agoStelara sales grew 0.3% to $2.45 billion in the quarter, driven by market growth and share gains for...
Pharmaceutical giant Takeda is shutting down its San Diego office
U-T San Diego· 10 hours agoPharmaceutical giant Takeda is shutting down its research and development hub in San Diego that...
Stelara interactions: Other medications, alcohol, and more
Medical News Today· 6 days agoStelara (ustekinumab) is a brand-name injectable drug prescribed for certain autoimmune conditions....
Higher NSAID Dose Raises CVD Risk in Ankylosing Spondylitis
Medscape· 7 days agoNSAIDs, the primary pain management therapy for AS, increased the risk for vascular events and...
Sketchy stem-cell treatments in Mexico led to drug-resistant infections
Live Science via Yahoo News· 3 days ago"They also are advised to...Arizona man had developed an infection in his elbow after traveling to...
Elizabeth “Betsy” Mellins, MD
San Jose Mercury News· 3 days agoThroughout, her research acumen and tireless work ethic were driven by her profound compassion for children living with autoimmune diseases.In a 2012 New England Journal of Medicine editorial ...
Celltrion USA's adalimumab-aaty biosimilar to HUMIRA® now available at low wholesale acquisition...
Bennington Banner· 7 days agoCelltrion USA announced today that adalimumab-aaty, the company's high-concentration (100 mg/mL) and citrate-free formulation biosimilar to HUMIRA ® (adalimumab), is now available at a low wholesale ...
Peninsula Asset Management Inc. Has $310,000 Stock Position in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 3 days agoPeninsula Asset Management Inc. trimmed its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 7.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities ...
Shore Point Advisors LLC Has $323,000 Stake in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 3 days agoShore Point Advisors LLC lessened its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 21.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange ...
